If you ignore conventional wisdom not to invest in small cap biotech stocks, sell the first price spike and think twice before attempting an encore.
"Nobody ever lost money taking a profit." - Bernard Baruch
Showed up on my landing page, too, but Yahoo! tailors the articles displayed based on user information. I had read the article off the landing page yesterday and may have a cookie my web browser retained or Yahoo! stored my IP address. Also, as a former shareholder (sold at $17, thank goodness), still have SPPI in an historical Yahoo! portfolio to track share price performance after I have sold to inform future decisions.
Just stopped in to gauge reaction to the article.
jet, you have prompted me to emerge from the shadows of non-participation. While your timetable may be aggressive, it's interesting to see you change your mind because a reply to one of my posts on the TSO board stuck in my mind (even prompting me to question my expectation of the eventual rise of electric cars). Welcome to the future!
aviacionado • Sep 19, 2010 7:32 PM
You apparently do not understand the technology. Electric cars will be able to match gasoline-powered vehicle performance without the noise and pollution.
jetbpc • Sep 20, 2010 9:11 AM
I'm buying stock in electric cord companies. Can you picture thousands of miles of electric cords all over the freeways as the traffic jams suck up all the battery power???
They may be able to build an electric car, but making it practical and useful is a complete different story...
Not so sure about natural gas prices taking off, but with "no near term liquidity concerns" per the CFO's conference call statement, this may be a tool from ruthless John's bag to get the likes of transportation partners to restructure the "significant amount of above-market rates and unused commitments" and KKR to settle their lawsuit. Otherwise, someone will be explaining in a deposition why XCO tanked the share price by threatening "restructuring in court" within ten days of reassuring investors, "We have $256 million of liquidity and we do not have any debt maturities until the middle of 2018. We remain liquidity focused to enhance our runway and continue implementing our improvement plan and we're evaluating additional capital structure initiatives."
Thanks for the reply. Sounds reasonable on the surface, but the trading volume is too low to make real money. Almost every penny stock - especially biotechs - sucks in people who lose money then can't let go. Maybe someday DSCO will achieve scale in marketing a product and you'll get your money back.
Just dropped in to see what was happening after seeing DSCO on the % gainers list on consecutive days. Why are you still hanging around the DSCO message board after more than a decade of frustration? Boggles the mind.
Hey, don't feel too bad. You can't have fared much worse than Bill Ackman has since he sold Pershing Square's position in 2014.
$65 is not that far off all-time highs, adjusted for splits. Maybe the share price is at or near equilibrium . Certainly faring better, relative to 52-week highs, than the darlings of the past few years like TSO and HFC.
VLO also is the majority holder of VLP units, so in addition to GP IDR's, VLO receives the tax-advantaged distributions attributable to all VLP unitholders.